Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:40 PM ET 8-K
Capital Raise Eva Live Inc GOAI

Eva Live Capital Raise

Eva Live Inc. filed a prospectus supplement to facilitate an existing equity purchase agreement with Hudson Global Ventures, LLC. The agreement allows the company to sell up to 5,000,000 shares of common stock for an aggregate price of up to $10 million. Additionally, the company issued a warrant to the investor for 275,000 shares at an exercise price of $0.01 per share.

Counterparty
Hudson Global Ventures, LLC
4:31 PM ET 8-K
Capital Raise Curis Inc CRIS

Curis Capital Raise of $8.5M

Curis, Inc. entered into a securities purchase agreement to raise approximately $8.5 million through the sale of 16,666,680 shares of common stock (or pre-funded warrants) and accompanying common warrants at a combined price of $0.51 per share. The company intends to use the proceeds to fund research and development activities, specifically to support operations through its initial Chronic Lymphocytic Leukemia (CLL) data readout expected in December 2026.

Value
$8.5M
4:24 PM ET 8-K
Divestiture Medtronic plc MDT

Medtronic Divestiture

Medtronic plc has completed the separation of its diabetes business, MiniMed Group, Inc., into an independent publicly traded company via a tax-free exchange offer. Medtronic exchanged its remaining 252,813,348 shares of MiniMed common stock for outstanding Medtronic ordinary shares in an offer that was 5.4x oversubscribed.

4:23 PM ET 8-K
M&A Deal Curaleaf Holdings, Inc. CURLF

Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.

Curaleaf Holdings, Inc. responded to Aurora Cannabis Inc.'s rejection of its enhanced acquisition proposal, challenging the Aurora Board's refusal to grant due diligence access. Curaleaf noted its offer represents an 86% premium to Aurora's unaffected 30-day VWAP and criticized Aurora for providing diligence access to other unnamed parties while obstructing Curaleaf's binding offer.

Counterparty
Aurora Cannabis Inc.
4:22 PM ET 8-K
Divestiture Cambium Networks Corp CMBMF

Cambium Networks Divestiture to Univastu UK Limited for $5.1M

Cambium Networks' subsidiary, Cambium Networks, Ltd (in administration), completed the sale of its remaining business and assets to Univastu UK Limited for approximately $5.1 million. The transaction includes the 'Cambium' brand name, intellectual property, and all shares in group subsidiaries across multiple countries, effectively disposing of the company's remaining product lines as a going concern.

Value
$5.1M
Counterparty
Univastu UK Limited
4:16 PM ET 8-K
M&A Deal Construction Partners, Inc. ROAD

Construction Partners M&A Deal with S.E. Cline Construction, Inc.

Construction Partners, Inc. (CPI) has completed the acquisition of S.E. Cline Construction, Inc., a commercial site development and underground utility construction company based in Palm Coast, Florida. The deal includes approximately 60 employees and a rail-served, permitted hot-mix asphalt plant site in Bunnell, Florida, which will be integrated into CPI's Florida platform, C.W. Roberts Contracting. This acquisition expands CPI's operations along the growing Interstate 95 corridor in northeast and central Florida.

Counterparty
S.E. Cline Construction, Inc.
4:10 PM ET 8-K
Clinical Trial Data SpyGlass Pharma, Inc. SGP

SpyGlass Pharma Clinical Trial Data

SpyGlass Pharma announced positive 4-year interim results from its first-in-human trial of the BIM-IOL System for glaucoma patients undergoing cataract surgery. The data showed a 37% reduction in mean intraocular pressure and 86% of patients remained off topical drops with no product-related adverse events reported.

Term
4 years
4:07 PM ET 8-K
M&A Deal CCO Holdings Capital Corp CHTR

CCO Holdings Capital M&A Deal with Cox Communications, Inc.

Charter Communications provided a status update regarding its completed transactions with Cox Communications. The company has posted a revised trending schedule to its investor relations website containing pro forma financial and operating information as if the deal had closed on January 1, 2024.

Counterparty
Cox Communications, Inc.
4:03 PM ET 8-K
M&A Deal ACV Auctions Inc. ACVA

ACV Auctions M&A Deal with Copart, Inc.

ACV Auctions Inc. has completed its merger with Copart, Inc., becoming a wholly owned subsidiary of Copart. The transaction was executed via a tender offer for all outstanding shares of ACV Stock at $10.50 per share, followed by a second-step merger under Section 251(h) of the DGCL.

Counterparty
Copart, Inc.
3:03 PM ET 8-K
M&A Deal Non Invasive Monitoring Systems Inc NIMU

Non Invasive Monitoring Systems M&A Deal with Gravitics, Inc.

Non-Invasive Monitoring Systems entered into a fourth amendment to its merger agreement with Gravitics, Inc. The amendment modifies the definition of the required 'Public Offering' to gross proceeds expected to be $50 million, with a minimum threshold of $40 million. All other terms of the previously announced merger remain unchanged.

Counterparty
Gravitics, Inc.
2:34 PM ET 8-K
Capital Raise Stonepeak-Plus Infrastructure Fund LP

Stonepeak-Plus Infrastructure Fund Capital Raise of $38.8M

Stonepeak-Plus Infrastructure Fund LP sold unregistered limited partnership units to third-party investors for approximately $38.77 million on October 1, 2026. The sale was part of a continuous private offering, with the fund and its affiliated vehicle raising a total of approximately $1.99 billion since inception in May 2025.

Value
$38.8M
2:16 PM ET 8-K
Nasdaq/NYSE Compliance Notice PLAYSTUDIOS, Inc. MYPS

PLAYSTUDIOS Nasdaq/NYSE Compliance Notice

PLAYSTUDIOS, Inc. has regained compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company achieved this by maintaining a closing bid price at or above $1.00 for ten consecutive business days following a 1-for-10 reverse stock split effected on September 30, 2026.

Counterparty
The Nasdaq Stock Market LLC
1:42 PM ET 8-K
Capital Raise Cottonwood Communities, Inc.

Cottonwood Communities Capital Raise of $2.08M

Cottonwood Communities, Inc. raised approximately $2.08 million through the sale of 210,135 shares of its Series 2025 Preferred Stock in a private placement offering. The shares were sold to accredited investors at a purchase price of $10.00 per share between September 22 and October 18, 2026. This activity is part of an ongoing private offering launched in December 2024 with a maximum target of $150 million.

Value
$2.08M
11:23 AM ET 8-K
Divestiture Adia Med, Inc. ADIA

Adia Med Divestiture to Larry A. Powalisz

Adia Med, Inc. entered into a Membership Interest Purchase Agreement to sell a 7% membership interest in its subsidiary, Adia Labs LLC, to the company's CEO, Larry A. Powalisz. The transaction is valued at $350,000 in cash, with the use of proceeds restricted to corporate purposes jointly approved by the company's independent directors.

Counterparty
Larry A. Powalisz
10:11 AM ET 8-K
Capital Raise Ford Credit Floorplan Master Owner Trust a

Ford Credit Floorplan Master Owner Trust a Capital Raise

Ford Credit Floorplan Master Owner Trust A entered into definitive transaction documents, including an Indenture Supplement and Account Control Agreement, for the issuance of Series 2026-3 asset-backed notes. The filing formalizes the legal structure for the trust's latest issuance of securities backed by dealer floorplan receivables.

9:29 AM ET 8-K
M&A Deal Barrel Energy Inc. BRLL

Barrel Energy Signs $20M M&A Deal with Maine Bio-Fuel, Inc.

Barrel Energy Inc. has signed a letter of intent to acquire a 51% controlling interest in Maine Bio-Fuel, Inc. (doing business as Maine Standard Biofuels) for $20 million in cash and stock. The closing is contingent upon Barrel completing a separate business combination with a company listed on a national exchange (Nasdaq or NYSE) and securing a qualifying credit facility to fund the cash portion of the deal.

Value
$20M
Counterparty
Maine Bio-Fuel, Inc.
9:21 AM ET 8-K
M&A Deal Tcgx Acquisition Corp. TCGX

Tcgx Acquisition Signs $361M M&A Deal with TriGemX Bio, Inc.

TCGX Acquisition Corp. (SPAC) has entered into a definitive business combination agreement with TriGemX Bio, Inc. at a pre-money equity value of $361 million. The transaction includes a concurrent $160 million PIPE financing and is expected to provide approximately $246 million in gross proceeds to fund Phase 3 development of elismetrep for migraine. Upon closing, expected in Q1 2027, the combined company will be named TriGemX Bio, Inc. and trade on Nasdaq under the ticker TGEM.

Value
$361M
Counterparty
TriGemX Bio, Inc.
9:06 AM ET 8-K
Clinical Trial Data Veradermics, Inc MANE

Veradermics Clinical Trial Data

Veradermics announced positive topline results from its Phase 3 '304' clinical trial of VDPHL01 for male pattern hair loss, meeting all primary and secondary endpoints with high statistical significance. The study demonstrated robust increases in hair count and rapid onset of activity as early as Month 2, with a favorable safety profile and no treatment-related serious adverse events. These results, combined with prior Phase 2/3 data, support a potential FDA submission for the first non-hormonal oral treatment for pattern hair loss.

Term
6 months
9:00 AM ET 8-K
M&A Deal Data I DAIO

Data I Signs $13.2M M&A Deal with V-TEK and A&J Programming

Data I/O Corporation has entered into a definitive agreement to acquire V-TEK and A&J Programming. To fund the transaction and provide working capital, the company also announced a $13.25 million private placement of convertible subordinated debentures and common shares at a conversion price of $2.68 per share.

Value
$13.2M
Counterparty
V-TEK and A&J Programming
8:59 AM ET 8-K
M&A Deal Cardinal Infrastructure Group Inc. CDNL

Cardinal Infrastructure Group Signs $358M M&A Deal with Hughes Brothers Construction Inc.

Cardinal Infrastructure Group entered into a definitive agreement to acquire Hughes Brothers Construction Inc., a Central Florida heavy civil and site development contractor, for an aggregate purchase price of $357.5 million. The consideration consists of $214.5 million in cash and $143.0 million in Class A common stock, with an additional earn-out potential of up to $162.5 million based on future EBITDA performance. The acquisition establishes a scaled platform for Cardinal in the fast-growing Florida market and is expected to close in the fourth quarter of 2026.

Value
$358M
Counterparty
Hughes Brothers Construction Inc.

“We are excited to welcome Hughes Brothers to Cardinal as we take another important step in our strategy to build the Southeast’s premier site development platform by moving into the fast-growing Central Florida market. Hughes Brothers is an exceptional founder-led business that culturally aligns with what we’re building. They bring an experienced team, both in terms of field personnel and corporate leadership, longstanding customer relationships, h”

Jeremy Spivey, CEO of Cardinal Infrastructure Group
8:47 AM ET 8-K
Capital Raise OS Therapies Inc OSTX

OS Therapies Capital Raise of $7.2M

OS Therapies announced the initial closing of a warrant exercise inducement and exchange offer, raising $7.2 million in gross proceeds from seven accredited investors. Participating holders exercised warrants at a reduced price of $1.30 per share in exchange for new warrants to purchase an equal number of shares at $1.40. The proceeds will fund regulatory filings and commercial preparation for Herlystic™ in the U.S., U.K., EU, and Australia.

Value
$7.2M
8:45 AM ET 8-K
Capital Raise Dogwood Therapeutics, Inc. DWTX

Dogwood Therapeutics Capital Raise of $5M

Dogwood Therapeutics entered into a subscription agreement to sell 4,098,360 shares of common stock to its largest shareholder, Sealbond Limited (a subsidiary of CK Life Sciences), in a $5 million private placement. The proceeds will be used to fund Phase 3 preparatory activities for Halneuron® and extend the company's operational runway through March 2027.

Value
$5M
Counterparty
Sealbond Limited
8:36 AM ET 8-K
M&A Deal Atkore Inc. ATKR

Atkore M&A Deal with Prysmian S.p.A.

Atkore Inc. completed its merger with Prysmian S.p.A., with Atkore becoming a wholly owned subsidiary of Prysmian. Shareholders of Atkore received $95.00 in cash per share. In connection with the closing, Atkore terminated its existing credit facilities and redeemed $400 million of its 4.25% Senior Notes due 2031.

Counterparty
Prysmian S.p.A.
8:19 AM ET 8-K
M&A Deal Fuller H B Co FUL

Fuller H B Signs $1.4B M&A Deal with Ancora Holdings Group LLC

H.B. Fuller's Board of Directors unanimously rejected a second unsolicited, non-binding proposal from Ancora Holdings Group LLC to acquire the Company's Building Adhesive Solutions (BAS) business for $1.2 billion to $1.4 billion. The Board determined the offer undervalued the segment and lacked sufficient detail, though the Company will conduct a market check for select market segments and product lines by year-end 2026 to evaluate potential divestitures for deleveraging.

Value
$1.4B
Counterparty
Ancora Holdings Group LLC
8:17 AM ET 8-K
Divestiture Mks Inc MKSI

Mks Divestiture to TTM Technologies, Inc. for $650M

MKS Inc. has entered into a definitive agreement to sell its Ophir Optics business to TTM Technologies, Inc. for $650 million in cash. The transaction, which represents an 18x multiple of projected 2026 Adjusted EBITDA, is expected to close in the second quarter of 2027 and aims to strengthen MKS's balance sheet while focusing on its core semiconductor and electronics markets.

Value
$650M
Counterparty
TTM Technologies, Inc.
8:16 AM ET 8-K
M&A Deal Ttm Technologies Inc TTMI

Ttm Technologies Signs $650M M&A Deal with MKS Inc.

TTM Technologies has entered into a definitive agreement to acquire the Ophir Optics business from MKS Inc. for approximately $650 million in an all-cash transaction. The acquisition adds high-precision infrared thermal imaging and laser optics capabilities to TTM's defense and industrial portfolio and is expected to close in the second quarter of 2027.

Value
$650M
Counterparty
MKS Inc.

“We are excited to announce our planned acquisition of the Ophir Optics business as another important step toward enhancing our long-term growth strategy by expanding our portfolio with mission-critical optical solutions for land, air, maritime, and unmanned platforms and our industrial portfolio.”

Edwin Roks, President and Chief Executive Officer
8:08 AM ET 8-K
Clinical Trial Data ArriVent BioPharma, Inc. AVBP

ArriVent BioPharma Clinical Trial Data

ArriVent BioPharma announced the publication of Phase 1b results for firmonertinib in the journal Cancer Cell, focusing on patients with advanced EGFR PACC-mutant non-small cell lung cancer (NSCLC). The data showed a confirmed overall response rate (ORR) of 68% at the 240 mg dose and a median progression-free survival of 16.0 months, supporting the ongoing global Phase 3 ALPACCA trial.

8:06 AM ET 8-K
M&A Deal Silence Therapeutics plc SLN

Silence Therapeutics Signs $1.3B M&A Deal with Merck KGaA, Darmstadt, Germany

Silence Therapeutics has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany for approximately $1.3 billion in cash. Under the terms of the deal, Silence shareholders will receive $20.00 per ADS, representing a 130% premium to the company's recent closing price. The acquisition aims to strengthen Merck KGaA's specialty and rare disease pipeline, specifically incorporating Silence's Phase 2 siRNA candidate, Divesiran.

Value
$1.3B
Counterparty
Merck KGaA, Darmstadt, Germany

“We are pleased to have reached this agreement with Merck KGaA, Darmstadt, Germany, which is the result of a competitive sale process and delivers significant, immediate and certain value to our shareholders.”

Iain Ross, Interim Principal Executive Officer and Chairman of the Silence Board

“The planned acquisition of Silence Therapeutics will strengthen our capabilities to serve patients with targeted specialty and rare diseases.”

Kai Beckmann, Chairman of the Executive Board and Group CEO of Merck KGaA, Darmstadt, Germany
8:00 AM ET 8-K
Capital Raise Super League Enterprise, Inc. SLE

Super League Enterprise Capital Raise of $135M

Super League stockholders approved a strategic investment from Metaplanet, Inc. involving the contribution of 2,100 Bitcoin and $2.5 million in cash. Upon closing, the company will be renamed Superplanet, Inc. and issue 44,859,400 shares of common stock at $3.00 per share, establishing a Bitcoin-based treasury platform.

Value
$135M
Counterparty
Metaplanet Holdings, Inc.

“I’m deeply grateful to our stockholders for their support. Their approval brings us one step closer to redefining what this company can become. If the transaction closes, we would no longer be defined solely by our current scale. Alongside an operating business that continues to serve many of the world’s most recognizable brands, we would have a treasury seeded with 2,100 Bitcoin and the potential to build a significant position over time.”

Matt Edelman, Chairman, Chief Executive Officer and President of Super League
7:42 AM ET 8-K
M&A Deal Centrus Energy Corp LEU

Centrus Energy Signs $116M M&A Deal with Westerman Holdings, LLC

Centrus Energy Corp. acquired 100% of Westerman Holdings, LLC, a U.S. equipment manufacturing and engineering firm, for approximately $116 million in a mix of cash and stock. The acquisition brings a key supplier of centrifuge components in-house to secure Centrus' supply chain and diversify its revenue base into non-nuclear industrial sectors. Westerman will operate as a wholly owned subsidiary, and its CEO Jacob Garrett will transition to President of the unit and Vice President of Centrus.

Value
$116M
Counterparty
Westerman Holdings, LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.